Targeted Single-Walled Carbon Nanotubes for Photothermal Therapy Combined with Immune Checkpoint Inhibition for the Treatment of Metastatic Breast Cancer

Abstract The greatest contributors to cancer mortality are metastasis and the consequences of its treatment. Here, we present a novel treatment of metastatic breast cancer that combines photothermal therapy with targeted single-walled carbon nanotubes (SWCNTs) and immunostimulation with a checkpoint...

Full description

Bibliographic Details
Main Authors: Patrick McKernan, Needa A. Virani, Gabriela N. F. Faria, Clément G. Karch, Ricardo Prada Silvy, Daniel E. Resasco, Linda F. Thompson, Roger G. Harrison
Format: Article
Language:English
Published: SpringerOpen 2021-01-01
Series:Nanoscale Research Letters
Subjects:
Online Access:https://doi.org/10.1186/s11671-020-03459-x
_version_ 1797722988936691712
author Patrick McKernan
Needa A. Virani
Gabriela N. F. Faria
Clément G. Karch
Ricardo Prada Silvy
Daniel E. Resasco
Linda F. Thompson
Roger G. Harrison
author_facet Patrick McKernan
Needa A. Virani
Gabriela N. F. Faria
Clément G. Karch
Ricardo Prada Silvy
Daniel E. Resasco
Linda F. Thompson
Roger G. Harrison
author_sort Patrick McKernan
collection DOAJ
description Abstract The greatest contributors to cancer mortality are metastasis and the consequences of its treatment. Here, we present a novel treatment of metastatic breast cancer that combines photothermal therapy with targeted single-walled carbon nanotubes (SWCNTs) and immunostimulation with a checkpoint inhibitor. We find that the selective near-infrared photothermal ablation of primary orthotopic EMT6 breast tumors in syngeneic BALB/cJ mice using an annexin A5 (ANXA5) functionalized SWCNT bioconjugate synergistically enhances an anti-cytotoxic T-lymphocyte-associated protein 4 (anti-CTLA-4)-dependent abscopal response, resulting in an increased survival (55%) at 100 days after tumor inoculation. In comparison, there was no survival at 100 days for either photothermal therapy by itself or immunostimulation by itself. Prior to photothermal therapy, the SWCNT-ANXA5 bioconjugate was administered systemically at a relatively low dose of 1.2 mg/kg, where it then accumulated in tumor vasculature via ANXA5-dependent binding. During photothermal therapy, the average maximum temperature in the tumor reached 54 °C (duration 175 s). The mechanism of prolonged survival resulting from combinatorial photothermal ablation and immune stimulation was evaluated by flow cytometric quantification of splenic antitumoral immune effector cells and serum cytokine quantification.
first_indexed 2024-03-12T09:56:44Z
format Article
id doaj.art-b977638808f64fcea32955f1aef0df5c
institution Directory Open Access Journal
issn 1556-276X
language English
last_indexed 2024-03-12T09:56:44Z
publishDate 2021-01-01
publisher SpringerOpen
record_format Article
series Nanoscale Research Letters
spelling doaj.art-b977638808f64fcea32955f1aef0df5c2023-09-02T12:11:45ZengSpringerOpenNanoscale Research Letters1556-276X2021-01-011611910.1186/s11671-020-03459-xTargeted Single-Walled Carbon Nanotubes for Photothermal Therapy Combined with Immune Checkpoint Inhibition for the Treatment of Metastatic Breast CancerPatrick McKernan0Needa A. Virani1Gabriela N. F. Faria2Clément G. Karch3Ricardo Prada Silvy4Daniel E. Resasco5Linda F. Thompson6Roger G. Harrison7Department of Neurology, Neurosurgery, and Radiation Oncology, University of Oklahoma Health Sciences CenterDepartment of Radiation Oncology, Brigham and Women’s Hospital, Harvard Medical School, and Dana-Farber Cancer InstituteSchool of Chemical, Biological and Materials Engineering, University of OklahomaSchool of Biomedical Engineering, University of OklahomaSchool of Chemical, Biological and Materials Engineering, University of OklahomaSchool of Chemical, Biological and Materials Engineering, University of OklahomaArthritis and Clinical Immunology Program, Oklahoma Medical Research FoundationSchool of Chemical, Biological and Materials Engineering, University of OklahomaAbstract The greatest contributors to cancer mortality are metastasis and the consequences of its treatment. Here, we present a novel treatment of metastatic breast cancer that combines photothermal therapy with targeted single-walled carbon nanotubes (SWCNTs) and immunostimulation with a checkpoint inhibitor. We find that the selective near-infrared photothermal ablation of primary orthotopic EMT6 breast tumors in syngeneic BALB/cJ mice using an annexin A5 (ANXA5) functionalized SWCNT bioconjugate synergistically enhances an anti-cytotoxic T-lymphocyte-associated protein 4 (anti-CTLA-4)-dependent abscopal response, resulting in an increased survival (55%) at 100 days after tumor inoculation. In comparison, there was no survival at 100 days for either photothermal therapy by itself or immunostimulation by itself. Prior to photothermal therapy, the SWCNT-ANXA5 bioconjugate was administered systemically at a relatively low dose of 1.2 mg/kg, where it then accumulated in tumor vasculature via ANXA5-dependent binding. During photothermal therapy, the average maximum temperature in the tumor reached 54 °C (duration 175 s). The mechanism of prolonged survival resulting from combinatorial photothermal ablation and immune stimulation was evaluated by flow cytometric quantification of splenic antitumoral immune effector cells and serum cytokine quantification.https://doi.org/10.1186/s11671-020-03459-xSingle-walled carbon nanotubesPhotothermal therapyAnnexin A5Breast cancerImmune checkpoint inhibitor
spellingShingle Patrick McKernan
Needa A. Virani
Gabriela N. F. Faria
Clément G. Karch
Ricardo Prada Silvy
Daniel E. Resasco
Linda F. Thompson
Roger G. Harrison
Targeted Single-Walled Carbon Nanotubes for Photothermal Therapy Combined with Immune Checkpoint Inhibition for the Treatment of Metastatic Breast Cancer
Nanoscale Research Letters
Single-walled carbon nanotubes
Photothermal therapy
Annexin A5
Breast cancer
Immune checkpoint inhibitor
title Targeted Single-Walled Carbon Nanotubes for Photothermal Therapy Combined with Immune Checkpoint Inhibition for the Treatment of Metastatic Breast Cancer
title_full Targeted Single-Walled Carbon Nanotubes for Photothermal Therapy Combined with Immune Checkpoint Inhibition for the Treatment of Metastatic Breast Cancer
title_fullStr Targeted Single-Walled Carbon Nanotubes for Photothermal Therapy Combined with Immune Checkpoint Inhibition for the Treatment of Metastatic Breast Cancer
title_full_unstemmed Targeted Single-Walled Carbon Nanotubes for Photothermal Therapy Combined with Immune Checkpoint Inhibition for the Treatment of Metastatic Breast Cancer
title_short Targeted Single-Walled Carbon Nanotubes for Photothermal Therapy Combined with Immune Checkpoint Inhibition for the Treatment of Metastatic Breast Cancer
title_sort targeted single walled carbon nanotubes for photothermal therapy combined with immune checkpoint inhibition for the treatment of metastatic breast cancer
topic Single-walled carbon nanotubes
Photothermal therapy
Annexin A5
Breast cancer
Immune checkpoint inhibitor
url https://doi.org/10.1186/s11671-020-03459-x
work_keys_str_mv AT patrickmckernan targetedsinglewalledcarbonnanotubesforphotothermaltherapycombinedwithimmunecheckpointinhibitionforthetreatmentofmetastaticbreastcancer
AT needaavirani targetedsinglewalledcarbonnanotubesforphotothermaltherapycombinedwithimmunecheckpointinhibitionforthetreatmentofmetastaticbreastcancer
AT gabrielanffaria targetedsinglewalledcarbonnanotubesforphotothermaltherapycombinedwithimmunecheckpointinhibitionforthetreatmentofmetastaticbreastcancer
AT clementgkarch targetedsinglewalledcarbonnanotubesforphotothermaltherapycombinedwithimmunecheckpointinhibitionforthetreatmentofmetastaticbreastcancer
AT ricardopradasilvy targetedsinglewalledcarbonnanotubesforphotothermaltherapycombinedwithimmunecheckpointinhibitionforthetreatmentofmetastaticbreastcancer
AT danieleresasco targetedsinglewalledcarbonnanotubesforphotothermaltherapycombinedwithimmunecheckpointinhibitionforthetreatmentofmetastaticbreastcancer
AT lindafthompson targetedsinglewalledcarbonnanotubesforphotothermaltherapycombinedwithimmunecheckpointinhibitionforthetreatmentofmetastaticbreastcancer
AT rogergharrison targetedsinglewalledcarbonnanotubesforphotothermaltherapycombinedwithimmunecheckpointinhibitionforthetreatmentofmetastaticbreastcancer